Three new CEOs Unplugged sessions have been added to the #MTC26 agenda, bringing together influential leaders from across medtech and health care delivery for candid conversations you won’t find anywhere else.

These executive-level discussions will explore the financial, business, and technology forces influencing investment, innovation, partnerships, and growth across the industry, only at The MedTech Conference, October 18-21 in Boston.

Curious about the leaders that you could meet at the global medtech industry event of the year? Explore the sample attendee list here — and register today to access the full MTC26 list and start requesting meetings.

Who’s Running Your Workforce? The CEO’s Dilemma in the Age of Agentic AI

Sponsored by Deloitte

Speed or safety? Automation or accountability? Efficiency or empathy? Agentic AI is compressing these tradeoffs into decisions MedTech CEOs can no longer defer. AI systems capable of reasoning, planning, and acting autonomously are moving from pilot to infrastructure faster than most organizations are prepared to govern them. Organizations taking a human-centric approach to AI are significantly more likely to exceed their return on investment expectations – yet most MedTech companies are still designing for people and machines separately, leaving enormous value and patient risk on the table. This panel focus on what matters most: As a CEO, how do you maintain clinical accountability when autonomous systems make thousands of micro-decisions daily? How do you build a culture where people feel empowered by AI rather than displaced by it? And how do you govern all of this without sacrificing the speed that makes agentic AI valuable? The leaders who will define the next decade are making bold, intentional choices now – before the relationship between human judgment and machine autonomy defines itself. 

Featured Speakers

Sheryl Jacobson (Moderator)

Global and US MedTech Practice Leader, Deloitte

Lisa Davis
Senior Vice President, Chief Human Resources Officer, Insulet Corporation

Waleed Hassanein
President & CEO, TransMedics Group, Inc. 

Sonal Matai
President, North America, Karl Storz

Value Creation: Portfolio, Innovation, and Execution

Sponsored by Boston Consulting Group

MedTech leaders are being asked to create growth in an environment where the traditional value-creation playbook is evolving. Companies are making sharper choices about where to focus, how to balance organic and inorganic growth, and how to fund the next wave of innovation. At the same time, they are rethinking how the organization itself needs to evolve, including how to structure businesses, where to build shared capabilities, how to operate across geographies, and how to redesign operating models.

This discussion will bring together both leading CEOs and healthcare investors to examine current white spaces, how to unlock and fund new sources of value, and how different innovation paradigms will shape the next phase of MedTech growth. 

Featured Speakers

Vikram Aggarwal (Moderator)

Managing Director & Partner, Global Sector Leader, Medical Devices and Technology, Boston Consulting Group (BCG)

Cathrin Petty
Global Head of HC, Co-Head of North America PE, CVC

Tim Schmid
Executive Vice President, Worldwide Chairman, MedTech, Johnson & Johnson

Bernard Zovighian

CEO, Edwards Lifesciences

Driving Change in an Ever-Turbulent World

Sponsored by Bain & Company

Medtech CEOs are navigating a moment of compounding pressure unlike any in recent memory. Regulatory environments are in flux. Macro and geopolitical factors are constantly in flux. Health system consolidation and reimbursement dynamics are reshaping the customer landscape. At the same time, artificial intelligence is creating new opportunities to accelerate innovation, strengthen connectivity and improve patient outcomes, while raising questions about use at the same time. Meanwhile, organizations that have been through years of restructuring, post-pandemic recovery, and portfolio rationalization are being asked to transform again, faster – with workforces that are stretched thin. This session brings together CEOs of leading medtech companies for a candid, unscripted conversation about what it actually takes to drive change in this environment – what separates the companies coming out stronger from those falling behind – and what excites them about the future of Med Tech. 

Featured Speakers

 Todd Johnson (Moderator)

Senior Partner and Global Head of MedTech & Life Sciences Tools, Bain & Company

Helen Giza 
CEO, Fresenius Medical Care

Spencer Stiles
President, Chief Operating Officer, Stryker Corporation

Bob White
President & CEO, Olympus Corporation